| Application no. and date | 00906094.8 (espacenet) (Federated) (European Patent Register), 20000218 | | Patent/reg. no. and date | DK/EP 1156813, 20080709 | | Publication date | 20011128 | | Priority no. and date | US 256824, 19990224 | | EP pub. no. and date |
EP 1156813 20011128 | | Effective date | | | Applicant/owner | Oncolytics Biotech Inc., Suite 210
1167 Kensington Crescent N. W.
Calgary, AB T2N 1X7, CA | | Applicant ref. no. | P44518DK01 | | Inventor | LEE, Patrick, W., K., 22 Varmoor Place, N.W.
Calgary, Alberta T3A 0A1, CA,
STRONG, James, 5071 Nesbitt Road N.W.
Calgary, Alberta T2K 2N6, CA,
COFFEY, Matthew, C., 2231 Bowness Road N.W.
Calgary, Alberta T2N 3L4, CA | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 35/76 (2006.01) , A61P 35/00 (2006.01) | | Title | Reovirus til behandling af cellulære proliferative lidelser | | Int. application no. | CA2000000178 | | Int. publication no. | WO2000050051 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
